A new review highlights how human evolution has shaped the presence of pathogenic variations in DNA damage repair (DDR) genes, offering a new perspective on why modern populations face increased cancer susceptibility. By connecting genetic change with the history of human populations, the article reveals how biological processes that once supported survival now also influence disease risk.

A new review article highlights the expanding importance of glutamine metabolism in shaping the tumor microenvironment, offering fresh perspectives on how metabolic interactions influence cancer progression and therapeutic response. The work brings together current understanding of how this essential nutrient drives communication between tumor cells and surrounding stromal components, opening new avenues for more effective cancer treatment strategies.

A new review has illuminated a critical but often overlooked dimension of autosomal dominant polycystic kidney disease (ADPKD)—its immune microenvironment. Traditionally regarded as a genetic disorder driven by mutations in the PKD1 and PKD2 genes, ADPKD is now being redefined by the recognition of chronic inflammation, immune cell infiltration, and immune signaling pathways as key contributors to disease progression.

A new wave of scientific understanding is placing ferroptosis, a distinct form of iron-dependent cell death, at the forefront of efforts to overcome drug resistance in digestive cancers. These cancers, which include gastric, colorectal, liver, pancreatic, and esophageal malignancies, remain among the most challenging to treat due to their ability to evade standard therapies.

A newly published review article highlights the critical role of fatty acid metabolism in shaping the tumor microenvironment and influencing cancer progression, offering fresh perspectives for the development of more effective therapies.

A new review article brings attention to the critical role of DNA methylation heterogeneity in shaping the tumor microenvironment, highlighting its growing importance in understanding cancer progression and advancing more precise treatment strategies.

A rapidly advancing area of biomedical innovation is shining a spotlight on miR-128-3p, a small yet powerful molecule with the potential to reshape how diseases—especially cancer—are detected, monitored, and treated. This microRNA, part of a broader class of non-coding RNAs, plays a critical role in regulating gene activity and maintaining cellular homeostasis.

A newly published review article brings fresh attention to ACSL4, a key enzyme increasingly recognized for its central role in the progression of Alzheimer’s disease. By connecting multiple biological processes, the findings position ACSL4 as a compelling focal point for future therapeutic innovation and a potential driver of disease mechanisms.